SMT201200060B - Fase precorritrice e sua utilizzazione per preparare il sale di magnesio tetraidrato di un enantiomero di omeprazolo - Google Patents
Fase precorritrice e sua utilizzazione per preparare il sale di magnesio tetraidrato di un enantiomero di omeprazoloInfo
- Publication number
- SMT201200060B SMT201200060B SM201200060T SM201200060T SMT201200060B SM T201200060 B SMT201200060 B SM T201200060B SM 201200060 T SM201200060 T SM 201200060T SM 201200060 T SM201200060 T SM 201200060T SM T201200060 B SMT201200060 B SM T201200060B
- Authority
- SM
- San Marino
- Prior art keywords
- prepare
- precursor phase
- tetrahydrate salt
- omeprazole enantiomer
- magnesium tetrahydrate
- Prior art date
Links
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical class N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title 1
- NZHDAMQFAJCLLC-UHFFFAOYSA-N magnesium;tetrahydrate Chemical compound O.O.O.O.[Mg] NZHDAMQFAJCLLC-UHFFFAOYSA-N 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1053419A FR2959509B1 (fr) | 2010-05-03 | 2010-05-03 | Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201200060B true SMT201200060B (it) | 2013-03-08 |
Family
ID=43465326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201200060T SMT201200060B (it) | 2010-05-03 | 2012-12-19 | Fase precorritrice e sua utilizzazione per preparare il sale di magnesio tetraidrato di un enantiomero di omeprazolo |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8592601B2 (it) |
| EP (1) | EP2385046B1 (it) |
| JP (1) | JP2011236210A (it) |
| CN (1) | CN102241671B (it) |
| CA (1) | CA2738543A1 (it) |
| ES (1) | ES2394688T3 (it) |
| FR (1) | FR2959509B1 (it) |
| SI (1) | SI2385046T1 (it) |
| SM (1) | SMT201200060B (it) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103044400A (zh) * | 2012-12-21 | 2013-04-17 | 北京华禧联合科技发展有限公司 | 埃索美拉唑镁盐及其制备方法 |
| CN103524491A (zh) * | 2013-10-16 | 2014-01-22 | 江南大学 | 埃索美拉唑镁盐四水合物的三种晶型及其制备方法 |
| CN104725357A (zh) * | 2013-12-24 | 2015-06-24 | 苏州联友制药技术有限公司 | 一种埃索美拉唑镁二水合物晶型b的制备方法 |
| FR3018812A1 (fr) | 2014-03-21 | 2015-09-25 | Minakem | Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole |
| CN104844572B (zh) * | 2015-04-02 | 2017-06-20 | 天津大学 | 一种奥美拉唑钠1,2‑丙二醇溶剂化物及制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0723436T3 (da) | 1994-07-08 | 2001-11-26 | Astrazeneca Ab | Tabletteret flerenhedsdoseringsform |
| SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
| US6262085B1 (en) * | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US7169793B2 (en) | 2002-06-27 | 2007-01-30 | Dr. Reddy's Laboratories Limited | Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| US20040242642A1 (en) | 2002-11-18 | 2004-12-02 | Dr. Reddy's Laboratories Limited | Crystalline esomeprazole compounds and process for the preparation thereof |
| WO2004089935A1 (en) | 2003-04-10 | 2004-10-21 | Hetero Drugs Limitd | Novel crystalline forms of s-omeprazole magnesium |
| WO2006096709A2 (en) | 2005-03-08 | 2006-09-14 | Dr. Reddy's Laboratories Ltd. | Process for preparing amorphous salts |
| WO2007031845A2 (en) | 2005-09-14 | 2007-03-22 | Glenmark Pharmaceuticals Limited | Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation |
| JP2010519284A (ja) | 2007-02-21 | 2010-06-03 | シプラ・リミテッド | エソメプラゾールマグネシウム二水和物の調製方法 |
| FR2920428B1 (fr) * | 2007-08-29 | 2012-06-15 | Univ Rouen | Procede de dedoublement de sels de l'omeprazole |
-
2010
- 2010-05-03 FR FR1053419A patent/FR2959509B1/fr not_active Expired - Fee Related
-
2011
- 2011-03-31 US US13/076,989 patent/US8592601B2/en not_active Expired - Fee Related
- 2011-04-20 JP JP2011093921A patent/JP2011236210A/ja not_active Withdrawn
- 2011-04-21 CA CA2738543A patent/CA2738543A1/fr not_active Abandoned
- 2011-04-29 SI SI201130011T patent/SI2385046T1/sl unknown
- 2011-04-29 EP EP11164323A patent/EP2385046B1/fr not_active Not-in-force
- 2011-04-29 ES ES11164323T patent/ES2394688T3/es active Active
- 2011-05-03 CN CN201110122717.XA patent/CN102241671B/zh not_active Expired - Fee Related
-
2012
- 2012-12-19 SM SM201200060T patent/SMT201200060B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2385046B1 (fr) | 2012-09-19 |
| JP2011236210A (ja) | 2011-11-24 |
| SI2385046T1 (sl) | 2013-02-28 |
| FR2959509A1 (fr) | 2011-11-04 |
| EP2385046A1 (fr) | 2011-11-09 |
| ES2394688T3 (es) | 2013-02-04 |
| US8592601B2 (en) | 2013-11-26 |
| US20110269798A1 (en) | 2011-11-03 |
| CA2738543A1 (fr) | 2011-11-03 |
| CN102241671B (zh) | 2014-12-03 |
| FR2959509B1 (fr) | 2012-07-13 |
| CN102241671A (zh) | 2011-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201300004B (it) | Fase precorritrice e sua utilizzazione per preparare il sale di magnesio tetraidrato di un enantiomero di omeprazolo | |
| HUS2100055I1 (hu) | IBAT-inhibitorok májbetegségek kezelésére | |
| SMT201600184B (it) | Sale di meglumina di 6-fluoro-3-idrossi-2-pirazincarbossammide | |
| EP2649517A4 (en) | Fast computer startup | |
| SMT201300008B (it) | Fase precorritrice e sua utilizzazione per preparare il sale di magnesio tetraidrato di un enantiomero di omeprazolo | |
| SMT201600370B (it) | Complessi chelati di oligonucleotidi | |
| SMT201600072B (it) | Sale sodico di 6-fluoro-3-idrossi-2-pirazina carbossammide | |
| IL245328A0 (en) | Pharmaceutical composition | |
| LT3246016T (lt) | Sausų miltelių vaisto forma, apimanti fosfodiesterazės inhibitorių | |
| SMT201500233B (it) | Metodi per rilevare anticorpi anti-farmaco | |
| ZA201104977B (en) | Removal of acid mists | |
| SMT201600171B (it) | Sale e solvati di un derivato di tetraidro-isochinolina | |
| EP2812279A4 (en) | LIQUID PHASE SYNTHESIS OF TRISILYLAMINE | |
| SI3199533T1 (sl) | Pirazolna spojina in njena farmacevtska uporaba | |
| AP3787A (en) | New form of administration of enkephalinase inhibitor | |
| EP2689772A4 (en) | COSMETICS SOLID | |
| EP2609209C0 (en) | COMPOUND SELECTION IN DRUG RESEARCH | |
| EP2609107C0 (en) | PROCESS FOR THE SYNTHESIS OF OLIGORIBONUCLEOTIDES | |
| EP2594246A4 (en) | LIQUID COSMETICS | |
| SMT201600474B (it) | Procedimento per la preparazione di pemetrexed e suo sale di lisina | |
| HRP20180567T1 (hr) | Farmaceutski pripravak omeprazola | |
| SMT201200060B (it) | Fase precorritrice e sua utilizzazione per preparare il sale di magnesio tetraidrato di un enantiomero di omeprazolo | |
| PL2666016T3 (pl) | Zastosowanie BUBR1 jako biomarkera odpowiedzi lekowej | |
| EP2736516A4 (en) | SUMOYLATION OF SERCA2A AND CARDIOVASCULAR DISEASES | |
| EP2578161A4 (en) | ULTRASOUND DEVICE |